Publication date: Oct 11, 2024
Few studies quantified the influence of the coronavirus disease 2019 (COVID-19) pandemic on medical teaching and scientific research activities in China. This is the first national study to investigate such topics from the viewpoint of physicians practicing obstetrics and gynecology in China. This is a national questionnaire survey with online interviews for respondents. This two-stage, stratified, cluster sampling method was applied based on city categories (categories 1 to 3 correspond to 30,000 beds, respectively), hospital levels (primary, secondary, and tertiary), and hospital types (general and specialized) in China among physicians practicing obstetrics and gynecology. Physicians documented notable alterations in both overall and specialized teaching and research engagements. Comparative analyses were conducted across diverse municipal and hospital attributes. Data were collected from a representative sample of 11,806 physicians from 779 hospitals across 157 cities and 31 provinces. Notably, except for online seminars, a minimum reduction of 20% in both overall and specialized teaching and research activities was observed among physicians. Up to 61. 7% (95% confidence interval 59. 3-64. 0) of physicians reported either a complete termination or a > 50% decline in resident training. Compared with category 1 cities and primary hospitals, category 3 cities and tertiary hospitals experienced greater reductions in items of resident or graduate education, visiting scholar, clinical trials, and laboratory studies (adjusted p values
Open Access PDF
Concepts | Keywords |
---|---|
China | COVID-19 pandemic |
Coronavirus | Mainland China |
Gynecology | Obstetrics and gynecology |
Interviews | Research |
Teaching |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
pathway | REACTOME | Reproduction |
disease | MESH | infection |
drug | DRUGBANK | Ademetionine |
drug | DRUGBANK | Ranitidine |
drug | DRUGBANK | Coenzyme M |
disease | MESH | tics |
drug | DRUGBANK | L-Valine |
drug | DRUGBANK | L-Citrulline |
drug | DRUGBANK | Indoleacetic acid |
drug | DRUGBANK | Etoperidone |
drug | DRUGBANK | Trestolone |
pathway | REACTOME | Translation |
disease | MESH | Rare Diseases |
disease | IDO | process |
drug | DRUGBANK | Calusterone |